I am happy to pick up shares in DSH at this ridiculous price. I think the wording in the trading update was poor:
"The Company presently anticipates FY2016 NPAT could be $5 million to $8 million below previous guidance of $45 million to $48 million".
I suspect a lot of sellers mistakenly thought NPAT would be between 5-8 million. At worst, NPAT is expected to be 40 million - only 16% from previous guidance. Yet the share price has fallen 60% in a few short weeks.
This has been oversold. Will double my holding tomorrow if this craziness continues.
Add to My Watchlist
What is My Watchlist?